Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eton Pharmaceutcials Inc 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010 USA

www.etonpharma.com Employees: 30 P: 847-787-7361

Description:

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Key Statistics

Overview:

Market Capitalization, $K 269,470
Enterprise Value, $K 253,460
Shares Outstanding, K 25,836
Annual Sales, $ 31,640 K
Annual Net Income, $ -940 K
Last Quarter Sales, $ 10,320 K
Last Quarter Net Income, $ 630 K
EBIT, $ -5,220 K
EBITDA, $ -4,200 K
60-Month Beta 1.25
% of Insider Shareholders 14.89%
% of Institutional Shareholders 27.86%
Float, K 21,989
% Float 85.11%
Short Volume Ratio 0.21

Growth:

1-Year Return 202.82%
3-Year Return 147.16%
5-Year Return 62.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.31%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.02 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr 116.67%
EPS Growth vs. Prev Year 200.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ETON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.29%
Return-on-Assets % -16.84%
Profit Margin % -2.97%
Debt/Equity 0.26
Price/Sales 8.57
Price/Cash Flow 3,285.56
Price/Book 16.98
Book Value/Share 0.62
Interest Coverage -0.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar